Ultrasound Can Be Used as a Painless and Viable Alternative to Losing Weight

A leading producer of aesthetic medical devices has developed the first noninvasive body contouring treatment approved by the United States Food and Drug Administration (FDA). Most women are unhappy about their abdominal area, and the new treatment offers a safe and efficient treatment for reducing abdominal fat by an average of 3.3–6.35 cm.

The treatment makes use of pulsed focused ultrasound to precisely target subcutaneous fat, without heating it, while keeping blood vessels, nerves, muscles and other surrounding tissue intact. The treatment does not require any surgery, anesthetics, or recovery time, and targets fat deposits that are difficult to remove with diet, and exercise alone.

The treatment was developed by Syneron Medical (Irvine, CA, USA) and is called UltraShape. The treatment destroys fat cells by emitting acoustic waves of ultrasonic energy, and focusing them into a confined focal volume. UltraShape transmits pulsed ultrasound, which restricts temperature elevation to less than 0.5 °C increase. The treatment targets only subcutaneous fat at a known depth, and destroys fat instantly, and selectively.

Shimon Eckhouse, PhD, Chairman of the Board of Directors for Syneron Candela, stated, "UltraShape uses ultrasound technology that was perfected in 10 years of research and development by world leading scientists and doctors to noninvasively destruct fat without any damage to surrounding tissue. UltraShape efficiency in noninvasive fat destruction has been studied and proven in more than 13 clinical studies with more than 900 patients treated by this technology. These studies have also demonstrated the excellent safety record of the technology as well as its ability to do it with no downtime to the patient."

Related Links:
Syneron Medical
Ultrashape